TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
114 hedge funds and large institutions have $296M invested in Tvardi Therapeutics, Inc. Common Stock in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
+13
Holders Change %
+12.87%
% of All Funds
2.84%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
31
Increased
36
Reduced
29
Closed
11
Calls
$11.2M
Puts
$15.1M
Net Calls
-$3.83M
Net Calls Change
-$5.03M
Top Buyers
| 1 |
BlackRock
New York
|
+$25.9M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$15.6M |
| 4 |
RCP
Rho Capital Partners
New York
|
+$9.2M |
| 5 |
Jennison Associates
New York
|
+$5.52M |
Top Sellers
| 1 |
Allianz Asset Management
Munich,
Germany
|
-$2.57M |
| 2 |
NC
Nexthera Capital
New York
|
-$2.39M |
| 3 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.1M |
| 4 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
-$1.93M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.66M |
